FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894560107> ?p ?o ?g. }

• W2894560107 endingPage "150" @default.
• W2894560107 startingPage "140" @default.
• W2894560107 abstract "Aim. The purpose of this study was to examine the association of increasing concentrations of endothelin-1 and soluble forms of ST2 protein (sST2) in the blood plasma of patients with chronic heart failure (CHF) who underwent implantation of a cardioverter-defibrillator, with the development of cardiovascular events (death from cardiovascular diseases, decompensated CHF, acute coronary syndrome or acute ischemic stroke) to determine whether these biomarkers can be used as predictors of an unfavorable course of the disease. Material and methods . A 6-month cohort study included 40 patients with CHF who received an ICD 4-12 weeks before their inclusion in the study. At the beginning of the study the concentrations of endothelin-1 and sST2 in plasma by ELISA were analyzed, along with conventional diagnostic techniques typical of a specialized cardiology clinic. Results. Phenotype with a favorable course of the disease was identified in 21 patients (group 1), and with a unfavorable course was seen in 19 (group 2). The concentration of endothelin-1 and sST2 in the blood plasma of the 2nd group patients was higher than in patients of the 1st group. The link of cardiovascular events with high levels of soluble ST2 protein and endothelin-1 in blood plasma has been identified. Variation of the decision rule threshold on the ROC-curve has allowed sST2 concentration of 34.93 ng/ml to be determined as a cutoff point. Accuracy of two-class classification (determination of the posterior probability of cardiovascular events) after identifying such cut-off point was characterized by 93% sensitivity and 72% specificity (area under ROC-curve – 0.87). If the value of the plasma concentrations of sST2 more 34.93 ng/ml the relative risk of cardiovascular events was 4.4 (95% CI 1.7–11.1). The use of endothelin-1 surplus in plasma (cut-off point – 0.34 fmol/ml) in predicting cardiovascular events was lower: the sensitivity – 88%, specificity – 68% (area under ROC-curve – 0.74). When the concentration of endothelin-1 in blood plasma was more than 0.34 fmol/ml the relative risk of cardiovascular events was 2.7 (95% CI 1.2–6.3). Conclusion. The increase in the sST2 and endothelin-1 concentration in blood plasma may be considered as a predictor of cardiovascular events in CHF patients after implantation of cardioverter-defibrillator." @default.
• W2894560107 created "2018-10-12" @default.
• W2894560107 creator A5002597544 @default.
• W2894560107 creator A5003603184 @default.
• W2894560107 creator A5013237023 @default.
• W2894560107 creator A5020481476 @default.
• W2894560107 creator A5021395512 @default.
• W2894560107 creator A5021407222 @default.
• W2894560107 creator A5029182512 @default.
• W2894560107 creator A5029866989 @default.
• W2894560107 creator A5067220707 @default.
• W2894560107 creator A5076814105 @default.
• W2894560107 date "2018-09-29" @default.
• W2894560107 modified "2023-10-11" @default.
• W2894560107 title "Prognosis of cardiovascular events after implantation of a cardioverterdefibrillator in patients with chronic heart failure: the value of increasing concentration of endothelin-1 and soluble forms of ST2 protein in blood plasma" @default.
• W2894560107 cites W1967511897 @default.
• W2894560107 cites W1973219094 @default.
• W2894560107 cites W1978436057 @default.
• W2894560107 cites W2003935940 @default.
• W2894560107 cites W2006109539 @default.
• W2894560107 cites W200771712 @default.
• W2894560107 cites W2011793066 @default.
• W2894560107 cites W2023936900 @default.
• W2894560107 cites W2033967875 @default.
• W2894560107 cites W2035288438 @default.
• W2894560107 cites W2042941094 @default.
• W2894560107 cites W2048813343 @default.
• W2894560107 cites W2068898313 @default.
• W2894560107 cites W2100267854 @default.
• W2894560107 cites W2110624183 @default.
• W2894560107 cites W2122622124 @default.
• W2894560107 cites W2157710399 @default.
• W2894560107 cites W2419640984 @default.
• W2894560107 cites W2460712538 @default.
• W2894560107 cites W2468415105 @default.
• W2894560107 cites W2475066103 @default.
• W2894560107 cites W2531042126 @default.
• W2894560107 cites W2548455412 @default.
• W2894560107 cites W2607896223 @default.
• W2894560107 cites W2612196928 @default.
• W2894560107 cites W4211082352 @default.
• W2894560107 doi "https://doi.org/10.20538/1682-0363-2018-3-140-150" @default.
• W2894560107 hasPublicationYear "2018" @default.
• W2894560107 type Work @default.
• W2894560107 sameAs 2894560107 @default.
• W2894560107 citedByCount "5" @default.
• W2894560107 countsByYear W28945601072020 @default.
• W2894560107 countsByYear W28945601072022 @default.
• W2894560107 countsByYear W28945601072023 @default.
• W2894560107 crossrefType "journal-article" @default.
• W2894560107 hasAuthorship W2894560107A5002597544 @default.
• W2894560107 hasAuthorship W2894560107A5003603184 @default.
• W2894560107 hasAuthorship W2894560107A5013237023 @default.
• W2894560107 hasAuthorship W2894560107A5020481476 @default.
• W2894560107 hasAuthorship W2894560107A5021395512 @default.
• W2894560107 hasAuthorship W2894560107A5021407222 @default.
• W2894560107 hasAuthorship W2894560107A5029182512 @default.
• W2894560107 hasAuthorship W2894560107A5029866989 @default.
• W2894560107 hasAuthorship W2894560107A5067220707 @default.
• W2894560107 hasAuthorship W2894560107A5076814105 @default.
• W2894560107 hasBestOaLocation W28945601071 @default.
• W2894560107 hasConcept C126322002 @default.
• W2894560107 hasConcept C144980905 @default.
• W2894560107 hasConcept C149601957 @default.
• W2894560107 hasConcept C164705383 @default.
• W2894560107 hasConcept C170493617 @default.
• W2894560107 hasConcept C2777698277 @default.
• W2894560107 hasConcept C2778198053 @default.
• W2894560107 hasConcept C2779134260 @default.
• W2894560107 hasConcept C500558357 @default.
• W2894560107 hasConcept C71924100 @default.
• W2894560107 hasConcept C72563966 @default.
• W2894560107 hasConceptScore W2894560107C126322002 @default.
• W2894560107 hasConceptScore W2894560107C144980905 @default.
• W2894560107 hasConceptScore W2894560107C149601957 @default.
• W2894560107 hasConceptScore W2894560107C164705383 @default.
• W2894560107 hasConceptScore W2894560107C170493617 @default.
• W2894560107 hasConceptScore W2894560107C2777698277 @default.
• W2894560107 hasConceptScore W2894560107C2778198053 @default.
• W2894560107 hasConceptScore W2894560107C2779134260 @default.
• W2894560107 hasConceptScore W2894560107C500558357 @default.
• W2894560107 hasConceptScore W2894560107C71924100 @default.
• W2894560107 hasConceptScore W2894560107C72563966 @default.
• W2894560107 hasIssue "3" @default.
• W2894560107 hasLocation W28945601071 @default.
• W2894560107 hasOpenAccess W2894560107 @default.
• W2894560107 hasPrimaryLocation W28945601071 @default.
• W2894560107 hasRelatedWork W2020276511 @default.
• W2894560107 hasRelatedWork W2048872450 @default.
• W2894560107 hasRelatedWork W2125804349 @default.
• W2894560107 hasRelatedWork W2350107389 @default.
• W2894560107 hasRelatedWork W2367687577 @default.
• W2894560107 hasRelatedWork W2377343248 @default.
• W2894560107 hasRelatedWork W2409836025 @default.
• W2894560107 hasRelatedWork W2978883476 @default.
• W2894560107 hasRelatedWork W2999832097 @default.
• W2894560107 hasRelatedWork W3040508483 @default.
• W2894560107 hasVolume "17" @default.

• next